BostonGene Announces $150 Million Series B Funding at a Multi-Billion Dollar Valuation, Propelling the Company to Unicorn Status

来源: 编辑: 发布: 2022-04-10 16:27

Financing Will Expedite R&D, Clinical Expansion, and International Availability of BostonGene Tumor PortraitTM Tests

WALTHAM, Mass.--(BUSINESS WIRE)--BostonGene today announced the completion of the $150 million Series B funding. NEC Corporation (NEC; TSE: 6701) led the financing with participation from Impact Investment Capital and Japan Industrial Partners. The capital will be used to scale BostonGene’s growth, including continued innovation, clinical and research partnerships, and international expansion. Further, leveraging NEC’s robust infrastructure, BostonGene and NEC intend to form a joint venture to bring lifesaving solutions to patients in Japan and other Asian countries.

“Many academic and community oncologists across the United States have already adopted BostonGene’s Molecular Portrait Test to improve their patients’ quality of care,” said Takayuki Morita, President and CEO at NEC Corporation. “NEC recently launched a healthcare and life science business unit that utilizes AI and other digital technologies as a key initiative within our 2025 Mid-term Management Plan. We are thrilled to expand on our strategic partnership with BostonGene to advance how physicians treat their patients and dramatically improve clinical outcomes in the U.S., Japan, and the rest of the world.”

“BostonGene has a unique opportunity to build a very large economic value that creates an even larger social impact. That combination is extremely rare, and I am excited and humbled by it,” said Andrew Feinberg, President, and CEO at BostonGene. “This capital positions us well to execute on our vision to enable personalized treatment of cancer patients based on integrated molecular profiles of the tumor, tumor microenvironment, and host immunity.”

BostonGene’s innovative computational platform performs AI-based molecular and immune profiling to discover correlations between tumor genomics, a patient’s immune system, and the effectiveness of all available approved and investigational treatments. The BostonGene Tumor Portrait™ Tests, a sophisticated analysis of the tumor and tumor microenvironment (TME), reveals critical drivers of each tumor, including immune microenvironment properties, actionable mutations, and biomarkers of response to diverse therapies, and recommended therapies. BostonGene’s integrated model of tumor genetics, transcriptomics, microenvironment, and tumor composition provides a 360° overview of a patient tumor to give physicians invaluable insights into potential treatment options.

About BostonGene Corporation

BostonGene’s mission is to power healthcare’s transition to personalized medicine using our AI-based molecular and immune profiling to improve the standard of care, accelerate research, and improve economics. BostonGene Tumor PortraitTM Tests reveal key drivers of each tumor, including immune microenvironment properties, actionable mutations, biomarkers of response to diverse therapies, and recommended therapies. Through these comprehensive analyses, BostonGene Tumor PortraitTM Tests generate a personalized roadmap for therapeutic decision-making for each cancer patient. For more information, visit BostonGene at http://www.BostonGene.com.

About NEC Corporation

NEC Corporation has established itself as a leader in the integration of IT and network technologies while promoting the brand statement of “Orchestrating a brighter world.” NEC enables businesses and communities to adapt to rapid changes to promote a more sustainable world for everyone. For more information, visit NEC at https://www.nec.com.

About Impact Investment Capital

Impact Investment Capital invests in opportunities with the intention to generate a measurable, beneficial social or environmental impact alongside a financial return.

About Japan Industrial Partners, Inc.

Japan Industrial Partners (JIP) is a private equity firm based in Tokyo, Japan. JIP aims to provide funds and solutions to businesses with significant growth opportunities.

猜你还想看:

其它网友:曲终人离场
评论:有一天,全世界都不要你了。不要慌,来找我,我会告诉你,我也不要你。

猫扑网友:Curtain情歌
评论:人生四项基本原则:懂得选择,学会放弃,耐得住寂寞,经得起诱惑。

搜狐网友:Lost love / 失爱
评论:每次考完试,我都要安慰自己,没关系,重在参与。

天涯网友:泡沫 forever/
评论:结婚的日子我已经定好了,现在就差定新郎了。

本网网友:A monologue. 独白。
评论:从小就有一个敌人叫“别人家的小孩”。他不爱玩游戏,从来只知道学习。

百度网友:heart┃ 锁心
评论:爷爷说他们那个年代。谁考试不会答。就答说毛主席万岁。没人敢打叉。

腾讯网友:℡說好不見面
评论:我的优点是:我很淑女;但是我的缺点是:我淑女的不明显。

凤凰网友:Cool| 卡其布
评论:女人最恨的男人是陈世美;男人最喜欢的女人是潘金莲。

淘宝网友:资本、principal
评论:现在告诉你们我结婚的日子喔,它正在海选中呢

天猫网友:人要靠自己
评论:你打扮成这样,是对这个世界有什么不满吗?